Wen Bo Wang
Chief Tech/Sci/R&D Officer at FATE THERAPEUTICS, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| J. Wolchko | M | 53 | 17 years | |
| William Rastetter | M | 76 | 13 years | |
| John Mendlein | M | 64 | 17 years | |
| Robert Epstein | M | 69 | 10 years | |
| Shefali Agarwal | M | 50 | 5 years | |
| Tim Coughlin | M | 57 | 11 years | |
| Edward Dulac | M | 49 | 4 years | |
| Michael Lee | M | 45 | 6 years | |
| Robert Hershberg | M | 61 | 4 years | |
| Cindy Tahl | F | 51 | 15 years | |
| Yuan Xu | M | 56 | 3 years | |
| Bahram Valamehr | M | 47 | 6 years | |
| Karin Jooss | M | 59 | 5 years | |
| Jim Beitel | M | - | 7 years | |
| Sven Kili | M | 57 |
Standards Coordinating Body
| - |
| Maritza McIntyre | M | 58 |
Standards Coordinating Body
| - |
| Jerome C. Bressi | M | - | 6 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Amir Nashat | M | 51 | 13 years | |
| Cynthia Fisher | F | 63 |
ViaCell, Inc.
 ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 4 years |
| James Tullis | M | 76 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 2 years |
| Jan van Heek | M | 75 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 5 years |
| Vaughn M. Kailian | M | 79 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 3 years |
| Steve G. Dance | M | 72 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 3 years |
| Christoph Adams | M | 67 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 4 years |
| Erin E. Lanciani | F | 55 |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 1 years |
| Daniel Shoemaker | M | 56 | 12 years | |
| Christian Bloomgren | M | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 6 years |
| Chris Storgard | M | 58 | 2 years | |
| Mark Plavsic | M | 63 | 2 years | |
| Kathleen Hayes | F | - |
ViaCell, Inc.
ViaCell, Inc. Medical SpecialtiesHealth Technology ViaCell, Inc. provides and develops cellular medicine for the treatment of diseases. The firm develops medicines for treatment of cancer, genetic disorders, organ transplant tolerance, neurological disorders, and autoimmune diseases. The company was founded in April 2000 and is headquartered in Cambridge, MA. | 4 years |
| Sarah Cooley | M | - | 4 years | |
| Yu Waye Chu | M | 56 | 4 years | |
| Brian Powl | M | 50 | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 33 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Wen Bo Wang
- Personal Network
